Hölscher C
University College Dublin, Department of Physiology, Ireland.
Neuroreport. 1998 Apr 20;9(6):1245-8. doi: 10.1097/00001756-199804200-00052.
beta-Amyloid has been shown to be neurotoxic in vivo and in vitro. Free radical production and subsequent lipid oxidation after beta-amyloid application have been observed in vitro and are considered to be factors that contribute to the neurotoxicity. Field recordings in the area CA1 for 3 weeks showed a dose-dependent effect on amplitude after intracerebroventricular (i.c.v.) injections of 1, 5 or 10 nmol beta-amyloid (25-35). The nitric oxide synthase inhibitors 7-nitro indazole (30 mg/kg, i.p.) and 1-(2-trifluoromethylphenyl)imidazole (150 nmol, i.c.v.) which preferentially inhibit the neuronal isoform prevented this beta-amyloid-induced decay of synaptic transmission. The protective effect of these inhibitors was reversed by L-arginine (200 mg/kg, i.p.). The results support the theory that nitric oxide production contributes to beta-amyloid-induced neuronal degeneration or reduction of neurotransmission.
β-淀粉样蛋白已被证实在体内和体外均具有神经毒性。在体外已观察到β-淀粉样蛋白应用后自由基的产生及随后的脂质氧化,这些被认为是导致神经毒性的因素。在脑室内注射1、5或10 nmol β-淀粉样蛋白(25-35)后,对CA1区进行3周的场电位记录显示对波幅有剂量依赖性影响。优先抑制神经元型一氧化氮合酶的抑制剂7-硝基吲唑(30 mg/kg,腹腔注射)和1-(2-三氟甲基苯基)咪唑(150 nmol,脑室内注射)可防止这种β-淀粉样蛋白诱导的突触传递衰减。L-精氨酸(200 mg/kg,腹腔注射)可逆转这些抑制剂的保护作用。这些结果支持一氧化氮的产生促成β-淀粉样蛋白诱导的神经元变性或神经传递减少这一理论。